What is King Pharmaceuticals's program services — fee revenue?

King Pharmaceuticals (KG) reported program services — fee revenue of $3.12M in Q1 2026.

How has King Pharmaceuticals's program services — fee revenue changed year-over-year?

King Pharmaceuticals's program services — fee revenue increased by 286.6% year-over-year, from $807K to $3.12M.

What does program services — fee revenue mean?

Revenue generated from service fees, management fees, or administrative charges within the program services segment. This represents non-underwriting income streams that diversify the segment's revenue base.

King Pharmaceuticals KG Program Services — Fee revenue

Other segment segments

Legacy Reinsurance

$0—

Similar metrics at other companies

HIPOService and fee income

$3.2M+14.3%

LPROProgram fees — Total Revenue

$11.37M-25.2%

UVEFee income

$14.73M-9.5%

LNCFee income

$1.38B+0.3%

FOAPortfolio Management — Fee income

$493K-37.3%

WTMFee income

$43.2M-10.2%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FeeIncome.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's program services — fee revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's program services — fee revenue?: King Pharmaceuticals (KG) reported program services — fee revenue of $3.12M in Q1 2026.
How has King Pharmaceuticals's program services — fee revenue changed year-over-year?: King Pharmaceuticals's program services — fee revenue increased by 286.6% year-over-year, from $807K to $3.12M.
What does program services — fee revenue mean?: Revenue generated from service fees, management fees, or administrative charges within the program services segment. This represents non-underwriting income streams that diversify the segment's revenue base.